Beilu Pharmaceutical: Haichang Pharmaceutical passed the GMP certification of the Brazilian National Health Surveillance Agency

2025-09-02 15:43:40

Beilu Pharmaceutical announced that its controlling subsidiary, Haichang Pharmaceutical, recently passed the official on-site GMP certification from the Brazilian National Health Surveillance Agency (ANVISA). The certification covers the product iohexol, with the certification number 0137263/24-4. This certification lays a solid foundation for Haichang Pharmaceutical's successful entry into the Brazilian market and further expansion into other international markets, and is of positive significance to the Group's overall internationalization strategy.

VIS Visa

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Alibaba (BABA.N) priced an approximately $3.2 billion offering of zero-coupon convertible senior notes.
                            2025-09-11

                                    LG Energy Solution: Employees on business trips in the United States are asked to return to South Korea immediately or stay at their residence.
                            2025-09-06

                                    Oakland-San Francisco Bay Airport said it had contacted Tesla's (TSLA.O) public policy and business development teams.
                            2025-09-09

                                    Oracle (ORCL.N) reported first-quarter revenue of $14.93 billion, missing expectations.
                            2025-09-10

                                    Oracle (ORCL.N): Cloud computing revenue increased 28% year-on-year to $7.2 billion in the first quarter.
                            2025-09-10